The Russian vaccine developed against the new coronavirus – Sputnik V – is 95 percent effective, according to a second interim analysis of clinical trial data.
The Russian Ministry of Health reports that the results were obtained from volunteers 42 days after the injection of the first dose. The effectiveness after 28 days is 91.4%.
The vaccine, developed by the National Center for Epidemiology and Microbiology Gamaleya, in Moscow, is expected to be around eight euros per dose.
– .
Related posts:
Bach IOC Chairman Expresses Determination to Realize Tokyo Olympics "Good Outlook" | Reuters
Tuition Fees Waived for State-Commissioned Students in Bulgaria: Free Higher Education to Become a R...
China imposed restrictions on the construction of skyscrapers
Oil companies hit hard in third quarter by low oil price | NOW
